Robert L. Van Nostrand, Director of Sellas Life Sciences Group SLS, has filed 1 purchase and 5 sales on the open market. The latest trade was on 01/07.

RN

RN

Robert L. Van Nostrand

Director

Company

Sellas Life Sciences Group SLS

First filing

23/01/03

Trades

49 trades

Buys / sales

1 / 5

12-month net buying

No record

Last trade

01/07

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Sellas Life Sciences GroupSLS	Open-market buy	25/06/12	25/06/13	10,000 sh	$1.48	$14,800	+96.2%
IT Intra-Cellular Therapies	Open-market sale10b5-1 plan	24/06/18	24/06/21	20,000 sh2 trades	$75.91avg.	$1,518,199.24	−67.4%
IT Intra-Cellular Therapies	Open-market sale	24/02/27	24/02/28	20,000 sh2 trades	$72.93avg.	$1,458,650.07	−67.5%
IT Intra-Cellular Therapies	Open-market sale10b5-1 plan	23/04/17	23/04/19	10,000 sh	$63.00	$630,000	−51.7%